Shanghai Shen Lian Biomedical Corporation (688098.SS)
CNY 5.51
(0.73%)
CNY 5.51
(0.73%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 213.55 Million CNY | -13.61% |
| 2022 | 247.19 Million CNY | -8.93% |
| 2021 | 271.44 Million CNY | -3.96% |
| 2020 | 282.63 Million CNY | 35.33% |
| 2019 | 208.85 Million CNY | -5.31% |
| 2018 | 220.56 Million CNY | -8.69% |
| 2017 | 241.56 Million CNY | 15.41% |
| 2016 | 209.32 Million CNY | 10.38% |
| 2015 | 189.63 Million CNY | 19.15% |
| 2014 | 159.16 Million CNY | 5.54% |
| 2013 | 150.81 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 53.73 Million CNY | 31.33% |
| 2024 Q3 | 77.95 Million CNY | 288.49% |
| 2024 Q2 | 20.06 Million CNY | -62.66% |
| 2023 Q3 | 85.74 Million CNY | 210.82% |
| 2023 Q4 | 40.91 Million CNY | -52.28% |
| 2023 FY | 213.55 Million CNY | -13.61% |
| 2023 Q1 | 59.3 Million CNY | 94.67% |
| 2023 Q2 | 27.58 Million CNY | -53.49% |
| 2022 Q3 | 114.49 Million CNY | 212.13% |
| 2022 Q1 | 65.55 Million CNY | 11.65% |
| 2022 FY | 247.19 Million CNY | -8.93% |
| 2022 Q4 | 30.46 Million CNY | -73.39% |
| 2022 Q2 | 36.68 Million CNY | -44.04% |
| 2021 FY | 271.44 Million CNY | -3.96% |
| 2021 Q4 | 58.71 Million CNY | -33.05% |
| 2021 Q1 | 69.02 Million CNY | 220.6% |
| 2021 Q2 | 55.99 Million CNY | -18.88% |
| 2021 Q3 | 87.7 Million CNY | 56.61% |
| 2020 Q4 | 21.53 Million CNY | -83.22% |
| 2020 FY | 282.63 Million CNY | 35.33% |
| 2020 Q3 | 128.35 Million CNY | 164.49% |
| 2020 Q2 | 48.52 Million CNY | -42.39% |
| 2020 Q1 | 84.22 Million CNY | 254.5% |
| 2019 Q1 | 77.48 Million CNY | 185.8% |
| 2019 Q4 | 23.75 Million CNY | -69.39% |
| 2019 Q2 | 29.99 Million CNY | -61.29% |
| 2019 Q3 | 77.61 Million CNY | 158.76% |
| 2019 FY | 208.85 Million CNY | -5.31% |
| 2018 Q4 | 27.11 Million CNY | 0.0% |
| 2018 FY | 220.56 Million CNY | -8.69% |
| 2018 Q1 | 109.31 Million CNY | 0.0% |
| 2017 Q2 | 61.32 Million CNY | 0.0% |
| 2017 Q1 | 61.32 Million CNY | 21.57% |
| 2017 FY | 241.56 Million CNY | 15.41% |
| 2016 Q1 | 54.21 Million CNY | 0.0% |
| 2016 Q3 | 50.44 Million CNY | -6.95% |
| 2016 Q2 | 54.21 Million CNY | 0.0% |
| 2016 Q4 | 50.44 Million CNY | 0.0% |
| 2016 FY | 209.32 Million CNY | 10.38% |
| 2015 FY | 189.63 Million CNY | 19.15% |
| 2014 FY | 159.16 Million CNY | 5.54% |
| 2013 FY | 150.81 Million CNY | 0.0% |